Bayer found to have discredited industry after Roche row
A U.K. marketing watchdog has sided with Roche over Bayer after a spat between the companies boiled over, ruling…
Roche defends 6B franc Vabysmo peak target despite another miss
Roche’s Vabysmo disappointed investors again. In the second quarter, the eye drug’s sales of about 1.04 billion Swiss…
Sales for Roche’s Vabysmo rise again, but momentum is stalled
While Roche touted sales and market share increases for eye disease drug Vabysmo on Thursday, there is evidence…
Top pharmaceutical companies for innovation: Roche, AbbVie, Novartis, and more
The 2020 Pharmaceutical Invention and Innovation Indices, compiled by IDEA Pharma, were generated prior to the unfolding COVID-19…